Tiger Brokers

  • Quotes
  • Products
    • Cash Boost Account
    • US Stocks
    • US Fractional Shares
    • HK Stocks
    • China A-shares
    • Options
    • Futures
    • US Treasury
    • Auto-invest
    • Fixed Coupon Notes
    • Tiger BOSS Debit Card
    • Fund Mall
    • Tiger Vault
    • Tiger Open Platform
    • Wealth
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Tiger Vault
      • Features of Tiger Vault
      • Transaction Fees
    • Statement
      • Statement
      • Dividends
  • Learn
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
  • Careers
    • L.E.A.P Programme
    • Investment Representative
    • Careers Portal
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

OncoCyte Corporation

2.79
0.0000
Volume:52.66K
Turnover:150.44K
Market Cap:79.79M
PE:-0.83
High:2.98
Open:2.78
Low:2.75
Close:2.79
Loading ...
OverviewCompanyNewsFilings
Feb 12, 2019

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Aug 22, 2018

Beneficial Ownership Change

May 18, 2018

Beneficial Ownership Change

Apr 30, 2018

[Rev.]Annual Report

Apr 03, 2018

Beneficial Ownership Change

Mar 30, 2018

Beneficial Ownership Change

Nov 15, 2017

Beneficial Ownership Change

瘤细胞集团
Oct 12, 2017

Correspondence

Oct 19, 2016

[Amend]Public Prospectus

Oct 19, 2016

[Amend]Public Prospectus

初始注册新的证券——修改
Oct 18, 2016

Correspondence

Oct 18, 2016

Correspondence

初始注册新的证券——修改
Aug 29, 2016

Beneficial Ownership Change

May 24, 2016

[Rev.]Annual Report

May 24, 2016

[Rev.]Annual Report

FY 2015 ended 12/31/15 – amended
Dec 29, 2015

Correspondence

Dec 28, 2015

Correspondence

Dec 28, 2015

Correspondence

Nov 23, 2015

Correspondence

Oct 07, 2015

Correspondence

Analyst Rate

Buy
Buy
50.00%
Hold
50.00%
Sell
0.00%

Corporate Actions

Financial Report Announcement
May 12, 2025 Post Market
Financial Report Announcement
Mar 24, 2025 Post Market
Financial Report Announcement
Nov 12, 2024 Post Market
Financial Report Announcement
Aug 08, 2024 Post Market
Financial Report Announcement
May 15, 2024 Post Market

Dividend History

no data

No relevant data is available

Valuation Analysis

-1.28
Current
-4.06
Sector Average
56.93%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-1.28
Maximum
-0.32
+1 STD
1.09
Minimum
-20.27
-1 STD
-9.21
Average
-4.06

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Fintech (Singapore) Pte. Ltd.
Email Address:
uservice@ttm.financial
User Agreement|Privacy Policy

Copyright © Tiger Fintech (Singapore) Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.